The long term objective of this proposal is to elucidate the general mechanisms responsible for the specificity of splice site selection during nuclear pre-mRNA splicing in mammalian cells. The proposed experiments will address the role of general protein splicing factors on the selection of specific 5' and 3' splice sites in cellular and viral pre-mRNAs that are constitutively or alternatively spliced. New human protein splicing factors will be identified and isolated by homology to their yeast counterparts. The structure and function of selected protein splicing factors will be examined in detail with respect to their roles in specific steps of splicing and in splice site selection. The expression of genes for protein splicing factors that affect splice site selection in vitro in a concentration-dependent manner will be measured in different cell lines and tissues. The possible regulation of this expression at the RNA and protein level by viral gene products and by oncogenic transformation will be studied. Molecular genetic, immunochemical, and biochemical approaches will be used to express recombinant splicing factors in bacteria, to study their structure and function, and to measure the expression of the corresponding genes in mammalian cells. These studies may uncover important roles for a subset of protein splicing factors in regulating the expression of numerous alternatively spliced viral and cellular genes, and in cellular reprogramming by viral gene products and by oncogenic transformation.
Tarumoto, Yusuke; Lu, Bin; Somerville, Tim D D et al. (2018) LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia. Mol Cell 69:1017-1027.e6 |
Xu, Yali; Milazzo, Joseph P; Somerville, Tim D D et al. (2018) A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia. Cancer Cell 33:13-28.e8 |
Huang, Yu-Han; Klingbeil, Olaf; He, Xue-Yan et al. (2018) POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Genes Dev 32:915-928 |
Livshits, Geulah; Alonso-Curbelo, Direna; Morris 4th, John P et al. (2018) Arid1a restrains Kras-dependent changes in acinar cell identity. Elife 7: |
Tiriac, Hervé; Belleau, Pascal; Engle, Dannielle D et al. (2018) Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov 8:1112-1129 |
Bhagwat, Anand S; Lu, Bin; Vakoc, Christopher R (2018) Enhancer dysfunction in leukemia. Blood 131:1795-1804 |
Banito, Ana; Li, Xiang; Laporte, Aimée N et al. (2018) The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Cancer Cell 34:346-348 |
Skucha, Anna; Ebner, Jessica; Schmöllerl, Johannes et al. (2018) MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. Nat Commun 9:1983 |
Banito, Ana; Li, Xiang; Laporte, Aimée N et al. (2018) The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Cancer Cell 33:527-541.e8 |
Lin, Kuan-Ting; Ma, Wai Kit; Scharner, Juergen et al. (2018) A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma. Genome Res : |
Showing the most recent 10 out of 610 publications